Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles G Drake

Showing results (131-140 of 266) with videos related to

Pageof 27
Sort By:
The Journal of Pathology|October 29, 2014
A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progressionBrian W Simons, Nicholas M Durham, Tullia C Bruno, et al.
The Prostate|January 4, 2020
Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapyJessica E Hawley, Samuel Pan, William D Figg, et al.
Prostate Cancer and Prostatic Diseases|October 16, 2019
A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancerAshley E Ross, Paula J Hurley, Phuoc T Tran, et al.
European Urology Oncology|August 15, 2019
Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder CancerMax Kates, Thomas R Nirschl, Alex S Baras, et al.
Journal for Immunotherapy of Cancer|September 1, 2023
KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy responseCasey R Ager, Mingxuan Zhang, Matthew Chaimowitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2003
CD4+ T cells pass through an effector phase during the process of in vivo tolerance inductionChing-Tai Huang, David L Huso, Zhenbing Lu, et al.
The Journal of Urology|November 25, 2015
A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder CancerJong Chul Park, Nilay M Gandhi, Michael A Carducci, et al.
The Prostate|June 19, 2008
Radiotherapy augments the immune response to prostate cancer in a time-dependent mannerTimothy J Harris, Edward L Hipkiss, Scott Borzillary, et al.
Oncotarget|October 27, 2017
Racial differences in prostate inflammation: results from the REDUCE studyAdriana C Vidal, Zinan Chen, Lauren E Howard, et al.
The Prostate|March 10, 2009
Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE IIMing-Hsi Wang, Kathy J Helzlsouer, Michael W Smith, et al.
Pageof 27

Showing results (131-140 of 266) with videos related to

Sort By:
Pageof 27
The Journal of Pathology|October 29, 2014
A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progressionBrian W Simons, Nicholas M Durham, Tullia C Bruno, et al.
The Prostate|January 4, 2020
Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapyJessica E Hawley, Samuel Pan, William D Figg, et al.
Prostate Cancer and Prostatic Diseases|October 16, 2019
A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancerAshley E Ross, Paula J Hurley, Phuoc T Tran, et al.
European Urology Oncology|August 15, 2019
Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder CancerMax Kates, Thomas R Nirschl, Alex S Baras, et al.
Journal for Immunotherapy of Cancer|September 1, 2023
KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy responseCasey R Ager, Mingxuan Zhang, Matthew Chaimowitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2003
CD4+ T cells pass through an effector phase during the process of in vivo tolerance inductionChing-Tai Huang, David L Huso, Zhenbing Lu, et al.
The Journal of Urology|November 25, 2015
A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder CancerJong Chul Park, Nilay M Gandhi, Michael A Carducci, et al.
The Prostate|June 19, 2008
Radiotherapy augments the immune response to prostate cancer in a time-dependent mannerTimothy J Harris, Edward L Hipkiss, Scott Borzillary, et al.
Oncotarget|October 27, 2017
Racial differences in prostate inflammation: results from the REDUCE studyAdriana C Vidal, Zinan Chen, Lauren E Howard, et al.
The Prostate|March 10, 2009
Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE IIMing-Hsi Wang, Kathy J Helzlsouer, Michael W Smith, et al.
Pageof 27